(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid

C142H194F5N15O9S — CID 157320623

IUPAC(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
SMILESCCCN(c1nc(Cc2ccc(F)cc2)c(C)s1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.Cc1nc(N(CCc2ccccc2)C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)no1
InChIInChI=1S/C38H51FN4O2S.C35H49F2N3O2.C35H47N5O3.C34H47F2N3O2/c1-3-20-43(38-40-35(27(2)46-38)23-28-14-16-32(39)17-15-28)33-18-21-41(22-19-33)24-31-25-42(26-34(31)29-10-6-4-7-11-29)36(37(44)45)30-12-8-5-9-13-30;1-2-39(19-9-10-26-15-16-32(36)33(37)22-26)30-17-20-38(21-18-30)23-29-24-40(25-31(29)27-11-5-3-6-12-27)34(35(41)42)28-13-7-4-8-14-28;1-26-36-35(37-43-26)40(22-17-27-11-5-2-6-12-27)31-18-20-38(21-19-31)23-30-24-39(25-32(30)28-13-7-3-8-14-28)33(34(41)42)29-15-9-4-10-16-29;1-2-38(20-15-25-13-14-31(35)32(36)21-25)29-16-18-37(19-17-29)22-28-23-39(24-30(28)26-9-5-3-6-10-26)33(34(40)41)27-11-7-4-8-12-27/h4,6-7,10-11,14-17,30-31,33-34,36H,3,5,8-9,12-13,18-26H2,1-2H3,(H,44,45);3,5-6,11-12,15-16,22,28-31,34H,2,4,7-10,13-14,17-21,23-25H2,1H3,(H,41,42);2-3,5-8,11-14,29-33H,4,9-10,15-25H2,1H3,(H,41,42);3,5-6,9-10,13-14,21,27-30,33H,2,4,7-8,11-12,15-20,22-24H2,1H3,(H,40,41)/t31-,34+,36+;29-,31+,34+;30-,32+,33+;28-,30+,33+/m0000/s1
InChIKeyBECUBIWXVSMYES-CPRGXIIVSA-N
MW2382.27 g/mol
LogP25.73
Rot. Bonds46

About (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid

(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid (PubChem CID 157320623) has the molecular formula C142H194F5N15O9S and a molecular weight of 2382.27 g/mol. Its IUPAC name is (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid.

Molecular Properties

Compound Name(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
PubChem CID157320623
Molecular FormulaC142H194F5N15O9S
Molecular Weight2382.27 g/mol
Exact Mass2380.48
IUPAC Name(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
SMILESCCCN(c1nc(Cc2ccc(F)cc2)c(C)s1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.Cc1nc(N(CCc2ccccc2)C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)no1
InChIInChI=1S/C38H51FN4O2S.C35H49F2N3O2.C35H47N5O3.C34H47F2N3O2/c1-3-20-43(38-40-35(27(2)46-38)23-28-14-16-32(39)17-15-28)33-18-21-41(22-19-33)24-31-25-42(26-34(31)29-10-6-4-7-11-29)36(37(44)45)30-12-8-5-9-13-30;1-2-39(19-9-10-26-15-16-32(36)33(37)22-26)30-17-20-38(21-18-30)23-29-24-40(25-31(29)27-11-5-3-6-12-27)34(35(41)42)28-13-7-4-8-14-28;1-26-36-35(37-43-26)40(22-17-27-11-5-2-6-12-27)31-18-20-38(21-19-31)23-30-24-39(25-32(30)28-13-7-3-8-14-28)33(34(41)42)29-15-9-4-10-16-29;1-2-38(20-15-25-13-14-31(35)32(36)21-25)29-16-18-37(19-17-29)22-28-23-39(24-30(28)26-9-5-3-6-10-26)33(34(40)41)27-11-7-4-8-12-27/h4,6-7,10-11,14-17,30-31,33-34,36H,3,5,8-9,12-13,18-26H2,1-2H3,(H,44,45);3,5-6,11-12,15-16,22,28-31,34H,2,4,7-10,13-14,17-21,23-25H2,1H3,(H,41,42);2-3,5-8,11-14,29-33H,4,9-10,15-25H2,1H3,(H,41,42);3,5-6,9-10,13-14,21,27-30,33H,2,4,7-8,11-12,15-20,22-24H2,1H3,(H,40,41)/t31-,34+,36+;29-,31+,34+;30-,32+,33+;28-,30+,33+/m0000/s1
InChIKeyBECUBIWXVSMYES-CPRGXIIVSA-N
XLogP25.73
TPSA239.89 Ų
H-Bond Donors4
H-Bond Acceptors21
Rotatable Bonds46
Heavy Atoms172
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002382.27
LogP ≤ 525.73
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1021

Analyze (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2R)-3-cyclobutyl-2-[(3S,4S)-3-(3-fluorophenyl)-4-[[4-[propyl(pyrimidin-2-yl)amino]piperidin-1-yl]methyl]pyrrolidin-1-yl]propanoic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-(3-fluorophenyl)-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid
CID 157270194

Frequently Asked Questions

What is the IUPAC name of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The IUPAC name of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid (CID 157320623) is (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid.
What is the SMILES notation for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The canonical SMILES for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid is CCCN(c1nc(Cc2ccc(F)cc2)c(C)s1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.CCN(CCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1.Cc1nc(N(CCc2ccccc2)C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)no1.
What is the InChIKey of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
The InChIKey is BECUBIWXVSMYES-CPRGXIIVSA-N. The full InChI is InChI=1S/C38H51FN4O2S.C35H49F2N3O2.C35H47N5O3.C34H47F2N3O2/c1-3-20-43(38-40-35(27(2)46-38)23-28-14-16-32(39)17-15-28)33-18-21-41(22-19-33)24-31-25-42(26-34(31)29-10-6-4-7-11-29)36(37(44)45)30-12-8-5-9-13-30;1-2-39(19-9-10-26-15-16-32(36)33(37)22-26)30-17-20-38(21-18-30)23-29-24-40(25-31(29)27-11-5-3-6-12-27)34(35(41)42)28-13-7-4-8-14-28;1-26-36-35(37-43-26)40(22-17-27-11-5-2-6-12-27)31-18-20-38(21-19-31)23-30-24-39(25-32(30)28-13-7-3-8-14-28)33(34(41)42)29-15-9-4-10-16-29;1-2-38(20-15-25-13-14-31(35)32(36)21-25)29-16-18-37(19-17-29)22-28-23-39(24-30(28)26-9-5-3-6-10-26)33(34(40)41)27-11-7-4-8-12-27/h4,6-7,10-11,14-17,30-31,33-34,36H,3,5,8-9,12-13,18-26H2,1-2H3,(H,44,45);3,5-6,11-12,15-16,22,28-31,34H,2,4,7-10,13-14,17-21,23-25H2,1H3,(H,41,42);2-3,5-8,11-14,29-33H,4,9-10,15-25H2,1H3,(H,41,42);3,5-6,9-10,13-14,21,27-30,33H,2,4,7-8,11-12,15-20,22-24H2,1H3,(H,40,41)/t31-,34+,36+;29-,31+,34+;30-,32+,33+;28-,30+,33+/m0000/s1.
What are the key properties of (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid?
(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid has a molecular weight of 2382.27 g/mol, XLogP of 25.73, 46 rotatable bonds, 4 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[2-(3,4-difluorophenyl)ethyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[[4-[(4-fluorophenyl)methyl]-5-methyl-1,3-thiazol-2-yl]-propylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[(5-methyl-1,2,4-oxadiazol-3-yl)-(2-phenylethyl)amino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid is sourced from PubChem (CID 157320623), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).